GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (STU:DMP) » Definitions » 5-Year Yield-on-Cost %

Dermapharm Holding SE (STU:DMP) 5-Year Yield-on-Cost % : 2.60 (As of Sep. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE 5-Year Yield-on-Cost %?

Dermapharm Holding SE's yield on cost for the quarter that ended in Jun. 2024 was 2.60.


The historical rank and industry rank for Dermapharm Holding SE's 5-Year Yield-on-Cost % or its related term are showing as below:

STU:DMP' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.99   Med: 2.2   Max: 5.97
Current: 2.6


During the past 11 years, Dermapharm Holding SE's highest Yield on Cost was 5.97. The lowest was 0.99. And the median was 2.20.


STU:DMP's 5-Year Yield-on-Cost % is ranked better than
55.12% of 508 companies
in the Drug Manufacturers industry
Industry Median: 2.175 vs STU:DMP: 2.60

Competitive Comparison of Dermapharm Holding SE's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's 5-Year Yield-on-Cost % falls into.



Dermapharm Holding SE 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Dermapharm Holding SE is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Dermapharm Holding SE  (STU:DMP) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Dermapharm Holding SE 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermapharm Holding SE Business Description

Traded in Other Exchanges
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals and cosmetics products. Parallel import brands business operates under the AxiCorp brand.

Dermapharm Holding SE Headlines

No Headlines